Green Extraction Method Boosts Honeybee Venom Protein Recovery and Bioactivity
Background
Honeybee venom (HBV) is a complex mixture of peptides and enzymes, including melittin and apamin, known for their potent anti-inflammatory, antimicrobial, and potential anticancer properties. Traditional extraction methods often rely on harsh organic solvents or aqueous solutions, which can degrade delicate proteins, reduce their bioactivity, or leave toxic residues, thereby limiting their therapeutic utility. This study addresses the critical need for a sustainable, efficient, and gentle extraction method that preserves the full bioactivity of honeybee venom proteins.
Results
The optimized DES-based extraction method significantly outperformed conventional aqueous extraction in both protein recovery and preserved bioactivity. Protein yield using the DES method was 2.3-fold higher (p<0.001) compared to traditional aqueous extraction, averaging 43.5 mg/g of venom versus 19.0 mg/g. This indicates a much more efficient capture of the valuable protein components. The DES-extracted honeybee venom proteins exhibited superior bioactivity, demonstrating a 65% greater antioxidant capacity and a 48% stronger inhibition of TNF-α (tumor necrosis factor-alpha) release in LPS-stimulated macrophages compared to proteins extracted conventionally (p<0.01 for both activities). Furthermore, SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) analysis confirmed better preservation of protein integrity with the DES method, showing that 95% of key venom peptides remained intact, compared to only 78% in aqueous extracts.
Why It Matters
This research introduces a sustainable and highly efficient method for extracting honeybee venom proteins, potentially unlocking their full therapeutic potential by ensuring higher yields and better preservation of bioactivity. By overcoming the limitations of traditional methods, this green extraction technique could significantly facilitate the development of new anti-inflammatory, antimicrobial, or anticancer agents from a natural source. This advancement could pave the way for more cost-effective and environmentally friendly production of pharmaceutical-grade honeybee venom components for future clinical applications. The next steps involve scaling up this process for industrial application and conducting in vivo studies to confirm the efficacy and safety of DES-extracted proteins.